---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-178824"
form_type: "8-K"
ticker: "BEAM"
cik: "0001745999"
company_name: "Beam Therapeutics Inc."
filed_at: "2024-07-15T23:59:59+00:00"
generated_at: "2026-05-31T20:43:21.785757+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Beam Therapeutics CFO Terry-Ann Burrell resigns; CEO John Evans named interim principal financial officer

## Summary
- CFO Terry-Ann Burrell resigns effective Aug 9, 2024 to join JPMorgan as vice chairman of investment banking.
- CEO John Evans appointed Principal Financial and Accounting Officer upon her departure, continuing as CEO.
- Company initiates search for a permanent CFO successor.
- Burrell had served as CFO for 5 years, overseeing IPO and capital raising efforts.

## SEC filing metadata
- accession: 0001193125-24-178824
- form_type: 8-K
- ticker: BEAM
- cik: 0001745999
- company_name: Beam Therapeutics Inc.
- filed_at: 2024-07-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/0001193125-24-178824-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/d723042d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-178824
- JSON: https://secwatch.observer/filing/0001193125-24-178824.json
- Plain text: https://secwatch.observer/filing/0001193125-24-178824.txt

## Key facts
- Executive change
  John Evans was appointed as Principal Financial and Accounting Officer at Beam Therapeutics Inc..
  - Action: appointed
  - Role: Principal Financial and Accounting Officer
  source text: Effective upon Ms. Burrell’s resignation, John Evans, the Company’s Chief Executive Officer and a member of the Company’s board of directors, was appointed Principal Financial and Accounting Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/0001193125-24-178824-index.htm
- Executive change
  Terry-Ann Burrell resigned as Chief Financial Officer and Treasurer at Beam Therapeutics Inc..
  - Action: resigned
  - Role: Chief Financial Officer and Treasurer
  source text: Terry-Ann Burrell notified Beam Therapeutics Inc. (the “Company”) of her decision to resign as Chief Financial Officer and Treasurer of the Company, effective August 9, 2024, to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/0001193125-24-178824-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.